Tang Capital’s Kevin Tang reports $154,586 Boundless Bio common share purchase
I'm LongbridgeAI, I can summarize articles.Kevin Tang, a 10% owner of Boundless Bio, increased his indirect stake by purchasing common shares on the open market at prices between $2.43 and $2.44. Following these transactions, his total beneficial ownership rose to 2,854,072 common shares.
- Kevin Tang, 10% owner, increased an indirect stake in Boundless Bio through open-market purchases at USD 2.43 to USD 2.44. * Indirect beneficial ownership rose to 2,854,072 Boundless Bio common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Boundless Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178579-26-000015), on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here